US Bancorp’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$103K Sell
2,830
-27
-0.9% -$982 ﹤0.01% 2405
2025
Q1
$103K Sell
2,857
-677
-19% -$24.5K ﹤0.01% 2375
2024
Q4
$149K Sell
3,534
-615
-15% -$25.9K ﹤0.01% 2192
2024
Q3
$230K Sell
4,149
-2,916
-41% -$162K ﹤0.01% 1963
2024
Q2
$290K Sell
7,065
-78
-1% -$3.21K ﹤0.01% 1802
2024
Q1
$334K Buy
7,143
+390
+6% +$18.2K ﹤0.01% 1738
2023
Q4
$323K Buy
6,753
+227
+3% +$10.9K ﹤0.01% 1752
2023
Q3
$233K Sell
6,526
-663
-9% -$23.6K ﹤0.01% 1761
2023
Q2
$332K Buy
7,189
+4,537
+171% +$209K ﹤0.01% 1602
2023
Q1
$106K Sell
2,652
-371
-12% -$14.9K ﹤0.01% 2153
2022
Q4
$140K Sell
3,023
-5,458
-64% -$253K ﹤0.01% 2052
2022
Q3
$351K Buy
8,481
+200
+2% +$8.28K ﹤0.01% 1563
2022
Q2
$495K Sell
8,281
-330
-4% -$19.7K ﹤0.01% 1443
2022
Q1
$625K Buy
8,611
+1,097
+15% +$79.6K ﹤0.01% 1428
2021
Q4
$631K Sell
7,514
-8,965
-54% -$753K ﹤0.01% 1416
2021
Q3
$1.49M Buy
16,479
+716
+5% +$64.5K ﹤0.01% 993
2021
Q2
$1.5M Sell
15,763
-4,030
-20% -$384K ﹤0.01% 1003
2021
Q1
$2.25M Buy
19,793
+4,858
+33% +$553K ﹤0.01% 805
2020
Q4
$2.07M Buy
14,935
+10,715
+254% +$1.48M ﹤0.01% 796
2020
Q3
$346K Buy
4,220
+4,111
+3,772% +$337K ﹤0.01% 1535
2020
Q2
$9K Buy
109
+62
+132% +$5.12K ﹤0.01% 3069
2020
Q1
$2K Hold
47
﹤0.01% 3408
2019
Q4
$2K Sell
47
-56
-54% -$2.38K ﹤0.01% 3438
2019
Q3
$4K Sell
103
-64
-38% -$2.49K ﹤0.01% 3293
2019
Q2
$11K Hold
167
﹤0.01% 3069
2019
Q1
$11K Buy
167
+105
+169% +$6.92K ﹤0.01% 3035
2018
Q4
$3K Sell
62
-71
-53% -$3.44K ﹤0.01% 3334
2018
Q3
$10K Hold
133
﹤0.01% 3122
2018
Q2
$10K Buy
133
+52
+64% +$3.91K ﹤0.01% 3140
2018
Q1
$4K Buy
81
+57
+238% +$2.82K ﹤0.01% 3377
2017
Q4
$1K Buy
24
+21
+700% +$875 ﹤0.01% 3546
2017
Q3
$0 Buy
+3
New ﹤0.01% 3632
2017
Q2
Sell
-125
Closed -$8K 3592
2017
Q1
$8K Sell
125
-4
-3% -$256 ﹤0.01% 3101
2016
Q4
$9K Buy
+129
New +$9K ﹤0.01% 3050
2016
Q3
Sell
-693
Closed -$34K 3598
2016
Q2
$34K Buy
693
+210
+43% +$10.3K ﹤0.01% 2590
2016
Q1
$31K Sell
483
-441
-48% -$28.3K ﹤0.01% 2599
2015
Q4
$104K Buy
924
+64
+7% +$7.2K ﹤0.01% 2045
2015
Q3
$83K Buy
860
+22
+3% +$2.12K ﹤0.01% 2178
2015
Q2
$85K Buy
+838
New +$85K ﹤0.01% 2254